Stephanie Markovina, MD, PhD, METEOR Clinical Trial and Project 1 Co-l (Cervix) Lead has been awarded an R01 grant from the National Institutes of Health in the amount of $2,865,128. Her work is entitled “The role of SERPINB3 in cervical cancer therapeutic resistance”.
Markovina awarded NIH R01
